Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 264

1.

Baseline Hemodynamics and Response to Contrast Media During Diagnostic Cardiac Catheterization Predict Adverse Events in Heart Failure Patients.

Denardo SJ, Vock DM, Schmalfuss CM, Young GD, Tcheng JE, O'Connor CM.

Circ Heart Fail. 2016 Jul;9(7). pii: e002529. doi: 10.1161/CIRCHEARTFAILURE.115.002529.

2.

Correction: Effects of Verapamil SR and Atenolol on 24-Hour Blood Pressure and Heart Rate in Hypertension Patients with Coronary Artery Disease: An International Verapamil SR-Trandolapril Ambulatory Monitoring Substudy.

Denardo SJ, Gong Y, Cooper-DeHoff RM, Farsang C, Keltai M, Szirmai L, Messerli FH, Bavry AA, Handberg EM, Mancia G, Pepine CJ.

PLoS One. 2016 Jun 3;11(6):e0157212. doi: 10.1371/journal.pone.0157212. eCollection 2016.

3.
4.

Effects of verapamil SR and atenolol on 24-hour blood pressure and heart rate in hypertension patients with coronary artery disease: an international verapamil SR-trandolapril ambulatory monitoring substudy.

Denardo SJ, Gong Y, Cooper-DeHoff RM, Farsang C, Keltai M, Szirmai L, Messerli FH, Bavry AA, Handberg EM, Mancia G, Pepine CJ.

PLoS One. 2015 Apr 2;10(4):e0122726. doi: 10.1371/journal.pone.0122726. eCollection 2015. Erratum in: PLoS One. 2016;11(6):e0157212.

5.

Detailed analysis of polymer response to delivery balloon expansion of drug-eluting stents versus bare metal stents.

Denardo SJ, Carpinone PL, Vock DM, Tcheng JE, Phillips HR 3rd, Willenberg BJ, Batich CD, Pepine CJ.

EuroIntervention. 2013 Jul;9(3):389-97. doi: 10.4244/EIJV9I3A62.

6.

Increased wave reflection and ejection duration in women with chest pain and nonobstructive coronary artery disease: ancillary study from the Women's Ischemia Syndrome Evaluation.

Nichols WW, Denardo SJ, Johnson BD, Sharaf BL, Bairey Merz CN, Pepine CJ.

J Hypertens. 2013 Jul;31(7):1447-54; discussion 1454-5. doi: 10.1097/HJH.0b013e3283611bac.

7.

Safety and efficacy of 188-rhenium-labeled antibody to melanin in patients with metastatic melanoma.

Klein M, Lotem M, Peretz T, Zwas ST, Mizrachi S, Liberman Y, Chisin R, Schachter J, Ron IG, Iosilevsky G, Kennedy JA, Revskaya E, de Kater AW, Banaga E, Klutzaritz V, Friedmann N, Galun E, Denardo GL, Denardo SJ, Casadevall A, Dadachova E, Thornton GB.

J Skin Cancer. 2013;2013:828329. doi: 10.1155/2013/828329. Epub 2013 Jan 10.

8.

Changes to polymer surface of drug-eluting stents during balloon expansion.

Denardo SJ, Carpinone PL, Vock DM, Batich CD, Pepine CJ.

JAMA. 2012 May 23;307(20):2148-50. doi: 10.1001/jama.2012.4111. No abstract available.

9.

In-vivo biodistribution and safety of 99mTc-LLP2A-HYNIC in canine non-Hodgkin lymphoma.

Zwingenberger AL, Kent MS, Liu R, Kukis DL, Wisner ER, DeNardo SJ, Taylor SL, Chen X, Lam KS.

PLoS One. 2012;7(4):e34404. doi: 10.1371/journal.pone.0034404. Epub 2012 Apr 24.

10.

Concepts, consequences, and implications of theranosis.

DeNardo GL, DeNardo SJ.

Semin Nucl Med. 2012 May;42(3):147-50. doi: 10.1053/j.semnuclmed.2011.12.003. Review.

PMID:
22475423
11.

A general chemical synthesis platform for crosslinking multivalent single chain variable fragments.

Schellinger JG, Kudupudi A, Natarajan A, Du W, DeNardo SJ, Gervay-Hague J.

Org Biomol Chem. 2012 Feb 28;10(8):1521-6. doi: 10.1039/c0ob01259a. Epub 2011 Dec 1.

12.

Effect of phosphodiesterase type 5 inhibition on microvascular coronary dysfunction in women: a Women's Ischemia Syndrome Evaluation (WISE) ancillary study.

Denardo SJ, Wen X, Handberg EM, Bairey Merz CN, Sopko GS, Cooper-Dehoff RM, Pepine CJ.

Clin Cardiol. 2011 Aug;34(8):483-7. doi: 10.1002/clc.20935. Epub 2011 Jul 21.

13.

An intravascular ultrasound analysis in women experiencing chest pain in the absence of obstructive coronary artery disease: a substudy from the National Heart, Lung and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE).

Khuddus MA, Pepine CJ, Handberg EM, Bairey Merz CN, Sopko G, Bavry AA, Denardo SJ, McGorray SP, Smith KM, Sharaf BL, Nicholls SJ, Nissen SE, Anderson RD.

J Interv Cardiol. 2010 Dec;23(6):511-9. doi: 10.1111/j.1540-8183.2010.00598.x. Epub 2010 Oct 4.

14.

Coronary revascularization strategy and outcomes according to blood pressure (from the International Verapamil SR-Trandolapril Study [INVEST]).

Denardo SJ, Messerli FH, Gaxiola E, Aranda JM Jr, Cooper-Dehoff RM, Handberg EM, Gong Y, Champion A, Zhou Q, Pepine CJ.

Am J Cardiol. 2010 Aug 15;106(4):498-503. doi: 10.1016/j.amjcard.2010.03.056.

15.

Blood pressure and outcomes in very old hypertensive coronary artery disease patients: an INVEST substudy.

Denardo SJ, Gong Y, Nichols WW, Messerli FH, Bavry AA, Cooper-Dehoff RM, Handberg EM, Champion A, Pepine CJ.

Am J Med. 2010 Aug;123(8):719-26. doi: 10.1016/j.amjmed.2010.02.014.

16.

Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease.

Cooper-DeHoff RM, Gong Y, Handberg EM, Bavry AA, Denardo SJ, Bakris GL, Pepine CJ.

JAMA. 2010 Jul 7;304(1):61-8. doi: 10.1001/jama.2010.884.

17.

Halogenated benzimidazole carboxamides target integrin alpha4beta1 on T-cell and B-cell lymphomas.

Carpenter RD, Natarajan A, Lau EY, Andrei M, Solano DM, Lightstone FC, Denardo SJ, Lam KS, Kurth MJ.

Cancer Res. 2010 Jul 1;70(13):5448-56. doi: 10.1158/0008-5472.CAN-09-3736. Epub 2010 Jun 8.

18.

The remarkable stability of chimeric, sialic acid-derived alpha/delta-peptides in human blood plasma.

Saludes JP, Natarajan A, DeNardo SJ, Gervay-Hague J.

Chem Biol Drug Des. 2010 May;75(5):455-60. doi: 10.1111/j.1747-0285.2010.00954.x.

19.

Outcomes Among hypertensive patients with concomitant peripheral and coronary artery disease: findings from the INternational VErapamil-SR/Trandolapril STudy.

Bavry AA, Anderson RD, Gong Y, Denardo SJ, Cooper-Dehoff RM, Handberg EM, Pepine CJ.

Hypertension. 2010 Jan;55(1):48-53. doi: 10.1161/HYPERTENSIONAHA.109.142240. Epub 2009 Dec 7.

20.

Pulse wave analysis of the aortic pressure waveform in severe left ventricular systolic dysfunction.

Denardo SJ, Nandyala R, Freeman GL, Pierce GL, Nichols WW.

Circ Heart Fail. 2010 Jan;3(1):149-56. doi: 10.1161/CIRCHEARTFAILURE.109.862383. Epub 2009 Nov 10.

21.

Health care in the United States in 2009: both sides of the "counter".

DeNardo GL, DeNardo SJ.

Cancer Biother Radiopharm. 2009 Oct;24(5):515-7. doi: 10.1089/cbr.2009.0702. No abstract available.

PMID:
19877880
22.

Exclusive antiplatelet therapy for percutaneous coronary intervention.

Denardo SJ.

J Am Coll Cardiol. 2009 May 19;53(20):1921-2; author reply 922-3. doi: 10.1016/j.jacc.2008.11.058. No abstract available.

23.

111In-LLP2A-DOTA Polyethylene Glycol-Targeting {alpha}4{beta}1 Integrin: Comparative Pharmacokinetics for Imaging and Therapy of Lymphoid Malignancies.

Denardo SJ, Liu R, Albrecht H, Natarajan A, Sutcliffe JL, Anderson C, Peng L, Ferdani R, Cherry SR, Lam KS.

J Nucl Med. 2009 Apr;50(4):625-34. doi: 10.2967/jnumed.108.056903. Epub 2009 Mar 16.

24.

Characteristics and outcomes of revascularized patients with hypertension: an international verapamil SR-trandolapril substudy.

Denardo SJ, Messerli FH, Gaxiola E, Aranda JM Jr, Cooper-Dehoff RM, Handberg EM, Gong Y, Champion A, Zhou Q, Pepine CJ.

Hypertension. 2009 Apr;53(4):624-30. doi: 10.1161/HYPERTENSIONAHA.108.111542. Epub 2009 Feb 23.

25.

Molecular specific and cell selective cytotoxicity induced by a novel synthetic HLA-DR antibody mimic for lymphoma and leukemia.

DeNardo GL, Mirick GR, Hok S, DeNardo SJ, Beckett LA, Adamson GN, Balhorn RL.

Int J Oncol. 2009 Feb;34(2):511-6.

PMID:
19148487
26.

Nanomolecular HLA-DR10 antibody mimics: A potent system for molecular targeted therapy and imaging.

DeNardo GL, Natarajan A, Hok S, Mirick G, DeNardo SJ, Corzett M, Sysko V, Lehmann J, Beckett L, Balhorn R.

Cancer Biother Radiopharm. 2008 Dec;23(6):783-96. doi: 10.1089/cbr.2008.0589.

27.

Update: Turning the heat on cancer.

DeNardo GL, DeNardo SJ.

Cancer Biother Radiopharm. 2008 Dec;23(6):671-80. doi: 10.1089/cbr.2008.0591. Review.

28.

Systemic radiotherapy can cure lymphoma: a paradigm for other malignancies?

DeNardo GL, DeNardo SJ, Balhorn R.

Cancer Biother Radiopharm. 2008 Aug;23(4):383-97. doi: 10.1089/cbr.2007.0523-U.

29.

Development of TNKase-specific cleavable peptide-linked radioimmunoconjugates for radioimmunotherapy.

Natarajan A, Kumaresan PR, Denardo SJ, Denardo GL, Mirick G, Lam KS.

Bioorg Med Chem Lett. 2008 Sep 1;18(17):4802-5. doi: 10.1016/j.bmcl.2008.07.097. Epub 2008 Jul 30.

PMID:
18701282
30.

Pre-clinical evaluation and efficacy studies of a melanin-binding IgM antibody labeled with 188Re against experimental human metastatic melanoma in nude mice.

Dadachova E, Revskaya E, Sesay MA, Damania H, Boucher R, Sellers RS, Howell RC, Burns L, Thornton GB, Natarajan A, Mirick GR, DeNardo SJ, DeNardo GL, Casadevall A.

Cancer Biol Ther. 2008 Jul;7(7):1116-27. Epub 2008 Apr 28.

PMID:
18535406
31.

NanoFerrite particle based radioimmunonanoparticles: binding affinity and in vivo pharmacokinetics.

Natarajan A, Gruettner C, Ivkov R, DeNardo GL, Mirick G, Yuan A, Foreman A, DeNardo SJ.

Bioconjug Chem. 2008 Jun;19(6):1211-8. doi: 10.1021/bc800015n. Epub 2008 Jun 3.

32.

Short communication: nanoparticle thermotherapy and external beam radiation therapy for human prostate cancer cells.

Lehmann J, Natarajan A, Denardo GL, Ivkov R, Foreman AR, Catapano C, Mirick G, Quang T, Gruettner C, Denardo SJ.

Cancer Biother Radiopharm. 2008 Apr;23(2):265-71. doi: 10.1089/cbr.2007.0411.

PMID:
18454696
33.

Effects of arterial stiffness, pulse wave velocity, and wave reflections on the central aortic pressure waveform.

Nichols WW, Denardo SJ, Wilkinson IB, McEniery CM, Cockcroft J, O'Rourke MF.

J Clin Hypertens (Greenwich). 2008 Apr;10(4):295-303. Review.

34.

Development of multivalent radioimmunonanoparticles for cancer imaging and therapy.

Natarajan A, Xiong CY, Gruettner C, DeNardo GL, DeNardo SJ.

Cancer Biother Radiopharm. 2008 Feb;23(1):82-91. doi: 10.1089/cbr.2007.0410.

PMID:
18298332
35.

Blood pressure targets after high-risk myocardial infarction: is it time to update the guidelines?

Denardo SJ, Anderson RD, Pepine CJ.

Hypertension. 2008 Jan;51(1):26-7. Epub 2007 Nov 26. No abstract available.

37.

Selective high-affinity ligand antibody mimics for cancer diagnosis and therapy: initial application to lymphoma/leukemia.

Balhorn R, Hok S, Burke PA, Lightstone FC, Cosman M, Zemla A, Mirick G, Perkins J, Natarajan A, Corzett M, DeNardo SJ, Albrecht H, Gregg JP, DeNardo GL.

Clin Cancer Res. 2007 Sep 15;13(18 Pt 2):5621s-5628s.

38.

Selecting an intervention time for intravascular enzymatic cleavage of peptide linkers to clear radioisotope from normal tissues.

Siantar CL, DeNardo GL, Lam K, Yuan A, Daly T, DeNardo SJ.

Cancer Biother Radiopharm. 2007 Aug;22(4):556-63.

PMID:
17803451
39.

Recombinant expression of the beta-subunit of HLA-DR10 for the selection of novel lymphoma targeting molecules.

Albrecht H, Cosman M, Ngu-Schwemlein M, Corzett M, Curran KW, Dolan C, Fang X, DeNardo SJ, DeNardo GL, Balhorn R.

Cancer Biother Radiopharm. 2007 Aug;22(4):531-42.

PMID:
17803448
40.

Effect of antilymphoma antibody, 131I-Lym-1, on peripheral blood lymphocytes in patients with non-Hodgkin's lymphoma.

Schillaci O, DeNardo GL, DeNardo SJ, Goldstein DS, Kroger LA, O'Donnell RT, Lamborn KR.

Cancer Biother Radiopharm. 2007 Aug;22(4):521-30.

PMID:
17803447
41.

Characteristics of dimeric (bis) bidentate selective high affinity ligands as HLA-DR10 beta antibody mimics targeting non-Hodgkin's lymphoma.

DeNardo GL, Hok S, Van Natarajan A, Cosman M, DeNardo SJ, Lightstone FC, Mirick GR, Yuan A, Perkins J, Sysko VV, Lehmann J, Balhorn RL.

Int J Oncol. 2007 Oct;31(4):729-40.

42.

Pharmacokinetic characterization in xenografted mice of a series of first-generation mimics for HLA-DR antibody, Lym-1, as carrier molecules to image and treat lymphoma.

DeNardo GL, Natarajan A, Hok S, Perkins J, Cosman M, DeNardo SJ, Lightstone FC, Mirick GR, Miers LA, Balhorn RL.

J Nucl Med. 2007 Aug;48(8):1338-47. Epub 2007 Jul 13.

43.

Development of anti-MUC1 di-scFvs for molecular targeting of epithelial cancers, such as breast and prostate cancers.

Albrecht H, Denardo GL, Denardo SJ.

Q J Nucl Med Mol Imaging. 2007 Dec;51(4):304-13. Epub 2007 May 1. Review.

44.

Construction of di-scFv through a trivalent alkyne-azide 1,3-dipolar cycloaddition.

Natarajan A, Du W, Xiong CY, DeNardo GL, DeNardo SJ, Gervay-Hague J.

Chem Commun (Camb). 2007 Feb 21;(7):695-7. Epub 2006 Nov 28.

PMID:
17392953
45.

Synthesis and radiolabeling of selective high-affinity ligands designed to target non-Hodgkin's lymphoma and leukemia.

Hok S, Natarajan A, Balhorn R, DeNardo SJ, DeNardo GL, Perkins J.

Bioconjug Chem. 2007 May-Jun;18(3):912-21. Epub 2007 Mar 21.

PMID:
17373772
46.

Thermal dosimetry predictive of efficacy of 111In-ChL6 nanoparticle AMF--induced thermoablative therapy for human breast cancer in mice.

DeNardo SJ, DeNardo GL, Natarajan A, Miers LA, Foreman AR, Gruettner C, Adamson GN, Ivkov R.

J Nucl Med. 2007 Mar;48(3):437-44.

47.

Direct antilymphoma activity of novel, first-generation "antibody mimics" that bind HLA-DR10-positive non-Hodgkin's lymphoma cells.

West J, Perkins J, Hok S, Balhorn R, Lightstone FC, Cosman M, DeNardo SJ, DeNardo GL.

Cancer Biother Radiopharm. 2006 Dec;21(6):645-54.

PMID:
17257080
48.

Recombinant antibodies: from the laboratory to the clinic.

Albrecht H, DeNardo SJ.

Cancer Biother Radiopharm. 2006 Aug;21(4):285-304. Review.

PMID:
16999595
49.

Targeted radionuclide therapy for solid tumors: an overview.

DeNardo SJ, Denardo GL.

Int J Radiat Oncol Biol Phys. 2006;66(2 Suppl):S89-95. Review.

PMID:
16979448
50.

Cure of incurable lymphoma.

DeNardo GL, Sysko VV, DeNardo SJ.

Int J Radiat Oncol Biol Phys. 2006;66(2 Suppl):S46-56. Review.

PMID:
16979440

Supplemental Content

Loading ...
Support Center